The stock opened at Rs 411.0 and touched an intraday high and low of Rs 414.0 and Rs 405.3, respectively, in the session so far. Shares of the company of Biocon Ltd. quoted a 52-week high of Rs 487.7 and a 52-week low of Rs 363.3.
Total market cap of the Biocon Ltd. stood at Rs 48774.38 crore at the time of writing this report.
The company reported consolidated net sales of Rs 2044.1 crore for the quarter ended 31-Mar-2021, up 8.79 per cent from previous quarter’s Rs 1878.9 crore and up 24.33 per cent from the year-ago quarter’s Rs 1644.1 crore.
The net profit for latest quarter stood at Rs 253.2 crore, up 105.19 per cent from the same quarter a year ago.
As of 30-Jun-2021, domestic institutional investors held 2.6 per cent stake in the company, while foreign institutional investors held 16.52 per cent and the promoters 60.64 per cent.
According to BSE data, the stock traded at a P/E multiple of 65.87 and a price-to-book ratio of 6.51. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Biocon Ltd. belongs to the Pharma – Indian industry.